Table 2 Characteristics of the patients according to serum 25(OH) D level
Variable | Total (n = 172) | Group1 < 20 N = 55 | Group2 [20,21,22,23,24,25,26,27,28,29,30] N = 96 | Group 3 > 30 N = 21 | p |
|---|---|---|---|---|---|
Age (years) ± SD | 53.005 ± 15.33 | 52.75 ± 14.94 | 55.56 ± 14.75 | 42.09 ± 15.33 | 0.001 |
Sex, (%) | 0.16 | ||||
male | 123 (71.5) | 34 (19.76) | 72 (41.86) | 17 (9.88) | |
Total (n = 172) | 49 (28.48) | 21 (12.20) | 24 (13.95) | 4 (2.32) | |
Co-morbidities (%) | |||||
HTN(+) | 53 (30.81) | 20 (11.62) | 10 (5.81) | 23 (13.37) | 0.06 |
DM(+) | 138 (80.23) | 43 (25.00) | 75 (43.60) | 20 (11.62) | 0.17 |
SBP ± SD | 125.76 ± 15.51 | 126.96 ± 16.33 | 124.58 ± 15.17 | 127.86 ± 15.04 | 0.63 |
DBP ± SD | 81.22 ± 10.94 | 81.42 ± 11.74 | 80.73 ± 11.00 | 82.84 ± 11.35 | 0.33 |
Hb (mg/dL) ± SD | 12.23 ± 2.03 | 11.55 ± 1.90 | 12.48 ± 2.09 | 12.92 ± 1.84 | 0.006 |
Albumin (mg/dL) ± SD | 4.05 ± 0.92 | 3.97 ± 0.37 | 4.08 ± 0.39 | 4.16 ± 0.49 | 0.10 |
Ca (mg/dL) ± SD | 9.10 ± 1.19 | 8.96 ± 0.89 | 9.16 ± 1.41 | 9.19 ± 0.70 | 0.56 |
P (mg/dL) ± SD | 3.59 ± 0.71 | 3.52 ± 0.56 | 3.65 ± 0.81 | 3.50 ± 0.60 | 0.48 |
iPTH (pg/mL) ± SD | 235.96 ± 83.43 | 247.41 ± 60.25 | 235.51 ± 92.79 | 207.48 ± 51.32 | 0.10 |
SCr | 2.66 ± 2.17 | 3.19 ± 2.91 | 2.36 ± 1.68 | 2.61 ± 1.66 | 0.081 |
eGFR (ml/min/1.72 m2) | 46.14 ± 26.52 | 43.87 ± 25.59 | 46.04 ± 26.49 | 52.61 ± 29.28 | 0.82 |
CKD stage, n (%) | 0.54 | ||||
Stage 2 (eGFR> 60) | 61 | 19 (11.04) | 33 (19.18) | 9 (5.23) | |
Stage 3 (eGFR30–59) | 51 | 19 (11.04) | 28 (16.27) | 4 (2.32) | |
Stage 4 (eGFR 15–29) | 37 | 8 (4.65) | 23 (13.37) | 6 (3.48) | |
Stage 5 (eGFR < 15) | 23 | 10 (5.81) | 11 (6.39) | 2 (1.16) | |